HHS nominee Azar says drug pricing a top priority

WASHINGTON (Reuters) – Alex Azar, the Republican nominee to head the U.S. Department of Health and Human Services and a former Eli Lilly & Co top executive, said on Wednesday that drug prices are too high and pledged to work on solutions despite his industry background.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *